# Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes

> **NCT04079881** · PHASE1,PHASE2 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 1 (actual)

## Conditions studied

- Type 1 Diabetes
- Hyperglycemia, Postprandial

## Interventions

- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT04079881
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-13
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Loss of funding
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04079881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04079881, "Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04079881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*